At a glance
- Originator Biosearch Italia
- Class Antibacterials
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 30 Sep 2005 Vicuron Pharmaceuticals has since been acquired by and merged into Pfizer